Gustavo Petro advocates for legalization as an end to the War on Drugs

Amid tensions with Trump, Gustavo Petro suggests drug policy change and cannabis exports

In Colombia, after years of numerous demands and efforts from the private sector, the medicinal and industrial uses of the cannabis plant have been authorized.

The new National Drug Policy aims to reduce harm, address historical inequalities, and regulate the cannabis industry with a focus on social justice, sustainable development, and productive inclusion.

Authorities discuss possible authorization of Coca and Poppy production for medicinal and industrial purposes

Latin America's economy is expected to contract by 7.2% this year, according to the June report from the World Bank

Decision reaffirms the six-month deadline for implementing rules on hemp for medicinal, pharmaceutical, and industrial use

Pharmacy student at Unifesp reveals, in a study, that cannabis can alleviate symptoms and improve the quality of life of patients with autoimmune diseases

The New Parliamentary Front will discuss public policies related to medicinal cannabis and industrial hemp

Gustavo Palhares believes that regulatory revision can relax prescriptions, expand access, and raise technical requirements in the medicinal cannabis sector

The decision of Judge Gustavo Müller Lorenzo considers unjust the resolution that differentiates compounding pharmacies from common pharmacies of Anvisa

Partnership with startup Buds INC investigates the physical and chemical properties of the material to extend the lifespan and resistance of recyclable products

Ease Labs is the second among the five companies with the highest market volume to announce price reductions

Cannabis Fair 2026, taking place from May 21 to 23 in São Paulo, will bring together companies, researchers, and investors, highlighting the industrial, technological, and regulatory advancements of cannabis in Brazil

The regulatory agency published the decision in the Official Gazette of the Union this Monday (8), allowing the inclusion of the dosage of 300 mg/ml

Projections indicate accelerated growth of the medicinal cannabis market by 2034, driven by regulatory changes and expanded therapeutic applications

Brazilian entrepreneur inaugurates USA Hemp Pharmaceuticals headquarters in Goiânia, expanding the brand's operations in Brazil with a focus on medical education, white label, and technology transfer of industrial hemp

On average, 63 patients with refractory epilepsy and 26 patients with aggressive behavior in ASD are treated

Pharmaceutical Assistance Coordination evaluates proposals in a public session. The announcement of the winning company is expected in 2023, subject to appeals and disqualifications.

After the approval of the bylaws, the objective now is to promote debates aimed at establishing a policy for palliative treatment of various diseases through medicinal cannabis